Systemic oxidative stress in classic Rett syndrome

Free Radical Biology and Medicine

Volumn 47, Issue 4, 2009, Pages 440-448

  De Felice, Claudio ^a   Ciccoli, Lucia ^b   Leoncini, Silvia ^b   Signorini, Cinzia ^b   Rossi, Marcello ^a   Vannuccini, Laura ^a   Guazzi, Gianni ^a   Latini, Giuseppe ^c   Comporti, Mario ^b   Valacchi, Giuseppe ^b,d   Hayek, Joussef ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c Clinical Physiology Institute   (Italy)

^d Kyung Hee University   (South Korea)

Author keywords

Autism spectrum disorders; Free radicals; Hypoxia; Isoprostanes; MeCP2; Oxidative stress; Pathogenesis; Rett syndrome

Indexed keywords

CARBONYL DERIVATIVE; CARBOXYHEMOGLOBIN; IRON; ISOPROSTANE DERIVATIVE; METHEMOGLOBIN; METHYL CPG BINDING PROTEIN 2; OXYGEN; OXYHEMOGLOBIN;

ADOLESCENT; ADULT; ARTICLE; AUTISM; BLOOD GAS ANALYSIS; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; ESTERIFICATION; FEMALE; GENE MUTATION; HUMAN; HYPOTHESIS; HYPOXIA; LUNG GAS EXCHANGE; LUNG PERFUSION; LUNG VENTILATION; MAJOR CLINICAL STUDY; MENTAL DEFICIENCY; OXIDATIVE STRESS; PATHOGENESIS; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; RATING SCALE; RETT SYNDROME; SCHOOL CHILD; X CHROMOSOME;

ADOLESCENT; ADULT; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; ERYTHROCYTES; F2-ISOPROSTANES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRON; MENTAL RETARDATION; METHYL-CPG-BINDING PROTEIN 2; MUTATION; OXIDATIVE STRESS; OXYGEN; PROTEIN CARBONYLATION; RETT SYNDROME; VENTILATION-PERFUSION RATIO;

EID: 67649850376     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.05.016     Document Type: Article

References (61)

1. Rett A. Uber ein eigartiges hirnatrophisches Syndrom bei Hyperammoniamie in Kindesalter. Wien Med. Wochenschr. 116 (1966) 723-738
2. Hagberg B., Aicardi J., Dias K., and Ramos O.A. progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls. Rett's syndrome: report of 35 cases. Ann. Neurol. 14 (1983) 471-479
3. Chahrour M., and Zoghbi H.Y. The story of Rett syndrome: from clinic to neurobiology. Neuron 56 (2007) 422-437
4. Amir R.E., Van den Veyver B., Wan M., Tran C.Q., Francke U., and Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23 (1999) 185-188
5. Chahrour M., Jung S.Y., Shaw C., Zhou X., Wong S.T., Qin J., and Zoghbi H.Y. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320 (2008) 1224-1229
6. Mari F., Azimonti S., Bertani I., Bolognese F., Colombo E., Caselli R., Scala E., Longo I., Grosso S., Pescucci C., Ariani F., Hayek G., Balestri P., Bergo A., Badaracco G., Zappella M., Broccoli V., Renieri A., Kilstrup-Nielsen C., and Landsberger N. CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Hum. Mol. Genet. 14 (2005) 1935-1946
7. Ariani F., Hayek G., Rondinella D., Artuso R., Mencarelli M.A., Spanhol-Rosseto A., Pollazzon M., Buoni S., Spiga O., Ricciardi S., Meloni I., Longo I., Mari F., Broccoli V., Zappella M., and Renieri A. FOXG1 is responsible for the congenital variant of Rett syndrome. Am. J. Hum. Genet. 83 (2008) 89-93
8. Moretti P., and Zoghbi H.Y. MeCP2 dysfunction in Rett syndrome and related disorders. Curr. Opin. Genet. Dev. 16 (2006) 276-281
9. Sierra C., Vilaseca M.A., Brandi N., Artuch R., Mira A., Nieto M., and Pineda M. Oxidative stress in Rett syndrome. Brain Dev. 23 Suppl. 1 (2001) 236-239
10. Formichi P., Battisti C., Dotti M.T., Hayek G., Zappella M., Federico A., and Vitamin E. serum levels in Rett syndrome. J. Neurol. Sci. 156 (1998) 227-230
11. Coyle J.T., and Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262 (1993) 689-695
12. Robb-Gaspers, S. J.; Connor, J. R. Oxidative stress-induced cell damage in the CNS: a proposal for a final common pathway. In: Connor, J. R., ed., Metal and oxidative damage in neurological disorders. New York: Plenum Press; 1997: 341-351.
13. Papanikolaou G., and Pantopoulos K. Iron metabolism and toxicity. Toxicol. Appl. Pharmacol. 202 (2005) 199-211
14. Thomas C.E., and Aust S.D. Rat liver microsomal NADPH-dependent release of iron from ferritin and lipid peroxidation. J. Free Radic. Biol. Med. 1 (1985) 293-300
15. Shadid M., Buonocore G., Groenendaal F., Moison R., Ferrali M., Berger H.M., and van Bel F. Effect of deferoxamine and allopurinol on non protein-bound iron concentrations in plasma and cortical brain tissue of newborn lambs following hypoxia ischemia. Neurosci. Lett. 248 (1998) 5-8
16. Ferrali M., Ciccoli L., and Comporti M. Allyl alcohol-induced hemolysis and its relation to iron release and lipid peroxidation. Biochem. Pharmacol. 38 (1989) 1819-1825
17. Morrow J.D., Awad J.A., Boss H.J., Blair I.A., and Roberts II L.J. Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc. Natl. Acad. Sci. USA 89 (1992) 10721-10725
18. Milne G.L., Musiek E.S., and Morrow J.D. F2-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers 10 Suppl. 1 (2005) 10-23
19. Signorini C., Perrone S., Sgherri C., Ciccoli L., Buonocore G., Leoncini S., Rossi V., Vecchio D., and Comporti M. Plasma esterified F2-isoprostanes and oxidative stress in newborns: role of non-protein-bound iron. Pediatr. Res. 63 (2008) 287-291
20. Signorini C., Comporti M., and Giorgi G. Ion trap tandem mass spectrometric determination of F2-isoprostanes. J. Mass Spectrom. 38 (2003) 1067-1074
21. Comporti M., Signorini C., Leoncini S., Buonocore G., Rossi V., and Ciccoli L. Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age. Free Radic. Biol. Med. 37 (2004) 724-732
22. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., Ahn B.W., Shaltiel S., and Stadtman E.R. Determination of carbonyl content in oxidatively modified proteins. In: Packer L., and Glazer A.N. (Eds). Methods in Enzymology, Vol. 186 (1990), Academic Press, Oxygen Radicals in Biological System, Part B. San Diego 464-478
23. Dalle-Donne I., Rossi R., Giustarini D., Milzani A., and Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin. Chim. Acta 329 (2003) 23-38
24. Buss H., and Winterbourn C.C. Protein carbonyl measurement by ELISA. Methods Mol. Biol. 186 (2002) 123-128
25. Rossi M., Vannuccini L., and Nigi F.A. computer program to evaluate ventilation-perfusion ratio distributions. Eur. Respir. J. 14 Suppl. 30 (1999) 227 [Abstract]
26. West J.B. Ventilation-perfusion inequality and overall gas exchange in computer models of the lung. Respir. Physiol. 7 (1969) 88-110
27. Colvin L., Fyfe S., Leonard S., Schiavello T., Ellaway C., de Klerk N., Christodoulou J., Msall M., and Leonard H. Describing the phenotype in Rett syndrome using a population database. Arch. Dis. Child. 88 (2003) 38-43
28. Halliwell B., and Gutteridge J.M.C. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 219 (1985) 1-14
29. Comporti M., Signorini C., Buonocore G., and Ciccoli L. Iron release, oxidative stress and erythrocyte ageing. Free Radic. Biol. Med. 32 (2002) 568-576
30. Ciccoli L., Rossi V., Leoncini S., Signorini C., Paffetti P., Bracci R., Buonocore G., and Comporti M. Iron release in erythrocytes and plasma non protein-bound iron in hypoxic and non hypoxic newborns. Free Radic. Res. 37 (2003) 51-58
31. Ciccoli L., Rossi V., Leoncini S., Signorini C., Blanco-Garcia J., Aldinucci C., Buonocore G., and Comporti M. Iron release, superoxide production and binding of autologous IgG to band 3 dimers in newborn and adult erythrocytes exposed to hypoxia and hypoxia-reoxygenation. Biochim. Biophys. Acta 1672 (2004) 203-213
32. Cirignotta F., Lugaresi E., and Montagna P. Breathing impairment in Rett syndrome. Am. J. Med Genet. 24 (1986) 167-173
33. Southall D.P., Kerr A.M., Tirosh E., Amos P., Lang M.H., and Stephenson J.B. Hyperventilation in the awake state: potentially treatable component of Rett syndrome. Arch. Dis. Child. 63 (1988) 1039-1048
34. Kerr A.M. A review of the respiratory disorder in the Rett syndrome. Brain Dev. 14 Suppl. (1992) 43-45
35. Elian M., and Rudolf N.M. EEG and respiration in Rett syndrome. Acta Neurol. Scand. 83 (1991) 123-128
36. Woodyatt G.C., and Murdoch B.E. The effect of the presentation of visual and auditory stimuli on the breathing patterns of two girls with Rett syndrome. J. Intellect. Disabil. Res. 40 (1996) 252-259
37. Julu P.O., Kerr A.M., Hansen S., Apartopoulos F., and Jamal G.A. Functional evidence of brain stem immaturity in Rett syndrome. Eur. Child Adolesc. Psychiatry 6 (1997) 47-54
38. Kerr A.M., and Julu P.O. Recent insights into hyperventilation from the study of Rett syndrome. Arch. Dis. Child. 80 (1999) 384-387
39. Julu P.O., Kerr A.M., Apartopoulos F., Al-Rawas S., Engerström I.W., Engerström L., Jamal G.A., and Hansen S. Characterization of breathing and associated central autonomic dysfunction in the Rett disorder. Arch. Dis. Child. 85 (2001) 29-37
40. Lugaresi E., Cirignotta F., and Montagna P. Abnormal breathing in the Rett syndrome. Brain Dev. 7 (1985) 329-333
41. Glaze D.G., Frost Jr. J.D., Zoghbi H.Y., and Percy A.K. Rett's syndrome: characterization of respiratory patterns and sleep. Ann. Neurol. 21 (1987) 377-382
42. Weese-Mayer D.E., Lieske S.P., Boothby C.M., Kenny A.S., Bennett H.L., and Ramirez J.M. Autonomic dysregulation in young girls with Rett syndrome during nighttime in-home recordings. Pediatr. Pulmonol. 43 (2008) 1045-1060
43. Gaultier C., and Gallego J. Neural control of breathing: insights from genetic mouse models. J. Appl. Physiol. 104 (2008) 1522-1530
44. Nagababu E., Ramasamy S., and Rifkind J.M. Site-specific cross-linking of human and bovine hemoglobins differentially alters oxygen binding and redox side reactions producing rhombic heme and heme degradation. Biochemistry 41 (2002) 7407-7415
45. Yakabe S., Soejima H., Yatsuki H., Tominaga H., Zhao W., Higashimoto K., Joh K., Kudo S., Miyazaki K., and Mukai T. MeCP2 knockdown reveals DNA methylation-independent gene repression of target genes in living cells and a bias in the cellular location of target gene products. Genes Genet. Syst. 83 (2008) 199-208
46. Wang H., Yuan G., Prabhakar N.R., Boswell M., and Katz D.M. Secretion of brain-derived neurotrophic factor from PC12 cells in response to oxidative stress requires autocrine dopamine signaling. J. Neurochem. 96 (2006) 694-705
47. Chahrour M., Jung S.Y., Shaw C., Zhou X., Wong S.T., Qin J., and Zoghbi H.Y. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320 (2008) 1224-1229
48. Pugazhenthi S., Phansalkar K., Audesirk G., West A., and Cabell L. Differential regulation of c-jun and CREB by acrolein and 4-hydroxynonenal. Free Radic. Biol. Med. 40 (2006) 21-34
49. Urdinguio R.G., Lopez-Serra L., Lopez-Nieva P., Alaminos M., Diaz-Uriarte R., Fernandez A.F., and Esteller M. Mecp2-null mice provide new neuronal targets for Rett syndrome. PLoS ONE 3 (2008) e3669
50. Phang J.M. The regulatory functions of proline and pyrroline-5-carboxylic acid. Curr. Top. Cell Regul. 25 (1985) 91-132
51. Krishnan N., Dickman M.B., and Becker D.F. Proline modulates the intracellular redox environment and protects mammalian cells against oxidative stress. Free Radic. Biol. Med. 44 (2008) 671-681
52. Acampa M., Guideri F., Hayek J., Blardi P., De Lalla A., Zappella M., and Auteri A. Sympathetic overactivity and plasma leptin levels in Rett syndrome. Neurosci. Lett. 432 (2008) 69-72
53. Guy J., Gan J., Selfridge J., Cobb S., and Bird A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 315 (2007) 1143-1147
54. Russell J.C., Blue M.E., Johnston M.V., Naidu S., and Hossain M.A. Enhanced cell death in MeCP2 null cerebellar granule neurons exposed to excitotoxicity and hypoxia. Neuroscience 150 (2007) 563-574
55. Fischer M., Reuter J., Gerich F.J., Hildbrandt B., Hägele S., Katschinski D., and Mueller M. Enhanced hypoxia susceptibility in hippocampal slices from a mouse model of Rett syndrome. J. Neurophysiol. 101 (2009) 1016-1032
56. Schüle B., Armstrong D.D., Vogel H., Oviedo A., and Francke U. Severe congenital encephalopathy caused by MECP2 null mutations in males: central hypoxia and reduced neuronal dendritic structure. Clin. Genet. 74 (2008) 116-126
57. Westberry J.M., Prewitt A.K., and Wilson M.E. Epigenetic regulation of the estrogen receptor alpha promoter in the cerebral cortex following ischemia in male and female rats. Neuroscience 152 (2008) 982-989
58. Lee B., Cao R., Choi Y.S., Cho H.Y., Rhee A.D., Hah C.K., Hoyt K.R., and Obrietan K. The CREB/CRE transcriptional pathway: protection against oxidative stress-mediated neuronal cell death. J. Neurochem. 108 (2009) 1251-1265
59. Pereira L.O., Nabinger P.M., Strapasson A.C., Nardin P., Gonçalves C.A., Siqueira R., and Netto C.A. Long-term effects of environmental stimulation following hypoxia-ischemia on the oxidative state and BDNF levels in rat hippocampus and frontal cortex. Brain Res. 1247 (2009) 188-195
60. Heck S., Lezoualc'h F., Engert S., and Behl C. Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappaB. J. Biol. Chem. 274 (1999) 9828-9835
61. Tropea D., Giacometti E., Wilson N.R., Beard C., McCurry C., Fu D.D., Flannery R., Jaenisch R., and Sur M. Partial reversal of Rett syndrome-like symptoms in MeCP2 mutant mice. Proc. Natl. Acad. Sci. USA 106 (2009) 2029-2034